Here is the synopsis of our sample research paper on Project Plan Overview. Have the paper e-mailed to you 24/7/365.
Essay / Research Paper Abstract
A 6 page project plan enabling a hospital to charge reduced prices for prescription drugs for uninsured and underinsured patients. In the past it has been impossible for any hospital to charge reduced prices for prescription drugs for fear of charges of fraud by Medicare. The Centers for Medicare and Medicaid Services (CMS) requires that Medicare prices be the lowest charged by any health care provider; its relatively new prescription discount plans bring with them permission for hospitals to charge less for uninsured or underinsured patients. Reducing charges to patients provides a service to patients and does not adversely affect the hospital. Bibliography lists 8 sources.
Page Count:
6 pages (~225 words per page)
File: CC6_KSprojPlOvrHos.rtf
Buy This Term Paper »
Unformatted sample text from the term paper:
has been impossible for any hospital to charge reduced prices for prescription drugs for fear of charges of fraud by Medicare. The Centers for Medicare and Medicaid Services (CMS)
requires that Medicare prices be the lowest charged by any health care provider; its relatively new prescription discount plans bring with them permission for hospitals to charge less for uninsured
or underinsured patients. Reducing charges to patients provides a service to patients and does not adversely affect the hospital. Introduction One of
the reasons that the current crisis has been so long in building - and in addressing - is that there are so many interlaced, interconnected factors affecting the total industry.
Virtually the only "winner" currently reasonably assured of continued success is the pharmaceutical industry, and that assurance is only fleeting. Big pharma is accused of gouging everyone -
patients, physicians, insurers and now even Medicare - and evidence consisting of a single tablet costing the consumer more than $2 each provides a compelling argument. A factor generally
not discussed, however, is the process that a drug developer must go through to gain approval for use by the Food and Drug Administration (FDA). It can cost billions
to bring a new drug to market, and the developer has patent protection only for relatively few years. To recoup its investment in the drug and to generate revenues
to use in the research and development of new products, pharmaceutical companies are faced with the unpleasant task of pricing their products well above where users and sellers of the
products would prefer to see them priced. The issue of drug costs falls outside the cost factors being considered here, however. This
...